Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bioceres Crop Solutions C...

    NASDAQ: BIOX · Real-Time Price · USD
    4.93
    0.01 (0.20%)
    At close: Jun 05, 2025, 3:59 PM
    5.13
    4.06%
    After-hours: Jun 05, 2025, 06:21 PM EDT

    Bioceres Crop Solutions Statistics

    Share Statistics

    Bioceres Crop Solutions has 62.71M shares outstanding. The number of shares has increased by -0.19% in one year.

    Shares Outstanding

    n/a
    		 62.71M

    Shares Change (YoY)

    n/a
    		 -0.19%

    Shares Change (QoQ)

    n/a
    		 -0.23%

    Owned by Institutions (%)

    n/a
    		 19.93%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,920

    FTD / Avg. Volume

    n/a
    		 2.63%

    Short Selling Information

    The latest short interest is 888.55K, so 1.47% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 888.55K

    Short % of Shares Out

    n/a
    		 1.47%

    Short % of Float

    n/a
    		 2.61%

    Short Ratio (days to cover)

    n/a
    		 6.99

    Valuation Ratios

    The PE ratio is 215.64 and the forward PE ratio is 24.9. Bioceres Crop Solutions's PEG ratio is -2.6.

    PE Ratio

    n/a
    		 215.64

    Forward PE

    n/a
    		 24.9

    PS Ratio

    n/a
    		 1.5

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 2.23

    P/FCF Ratio

    n/a
    		 36.94

    PEG Ratio

    n/a
    		 -2.6
    Financial Ratio History

    Enterprise Valuation

    Bioceres Crop Solutions has an Enterprise Value (EV) of 925.88M.

    EV / Sales

    n/a
    		 1.99

    EV / EBITDA

    n/a
    		 16.7

    EV / EBIT

    n/a
    		 22.19

    EV / FCF

    n/a
    		 48.9

    Financial Position

    The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.86.

    Current Ratio

    n/a
    		 1.24

    Quick Ratio

    n/a
    		 0.86

    Debt / Equity

    n/a
    		 0.86

    Debt / EBITDA

    n/a
    		 4.89

    Debt / FCF

    n/a
    		 14.31

    Interest Coverage

    n/a
    		 1.67

    Financial Efficiency

    Return on Equity is 1.03% and Return on Invested Capital is 4.23%.

    Return on Equity

    n/a
    		 1.03%

    Return on Assets

    n/a
    		 0.38%

    Return on Invested Capital

    n/a
    		 4.23%

    Revenue Per Employee

    n/a
    		 $1,162,071.37

    Profits Per Employee

    n/a
    		 $8,108.4

    Employee Count

    n/a
    		 400

    Asset Turnover

    n/a
    		 0.55

    Inventory Turnover

    n/a
    		 2.24

    Taxes

    Income Tax

    n/a
    		 3.78M

    Effective Tax Rate

    n/a
    		 37.65%

    Stock Price Statistics

    The stock price has increased by -54.44% in the last 52 weeks. The beta is 0.44, so Bioceres Crop Solutions's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.44

    52-Week Price Change

    n/a
    		 -54.44%

    50-Day Moving Average

    n/a
    		 4.47

    200-Day Moving Average

    n/a
    		 6.26

    Relative Strength Index (RSI)

    n/a
    		 55.85

    Average Volume (20 Days)

    n/a
    		 187,188

    Income Statement

    In the last 12 months, Bioceres Crop Solutions had revenue of 464.83M and earned 3.24M in profits. Earnings per share was 0.05.

    Revenue

    n/a
    		 464.83M

    Gross Profit

    n/a
    		 181.59M

    Operating Income

    n/a
    		 44.82M

    Net Income

    n/a
    		 3.24M

    EBITDA

    n/a
    		 55.46M

    EBIT

    n/a
    		 34.16M

    Earnings Per Share (EPS)

    n/a
    		 0.05
    Full Income Statement

    Balance Sheet

    The company has 44.47M in cash and 270.95M in debt, giving a net cash position of -226.47M.

    Cash & Cash Equivalents

    n/a
    		 44.47M

    Total Debt

    n/a
    		 270.95M

    Net Cash

    n/a
    		 -226.47M

    Retained Earnings

    n/a
    		 -10.66M

    Total Assets

    n/a
    		 835.2M

    Working Capital

    n/a
    		 94.9M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 41.72M and capital expenditures -22.78M, giving a free cash flow of 18.93M.

    Operating Cash Flow

    n/a
    		 41.72M

    Capital Expenditures

    n/a
    		 -22.78M

    Free Cash Flow

    n/a
    		 18.93M

    FCF Per Share

    n/a
    		 0.3
    Full Cash Flow Statement

    Margins

    Gross margin is 39.07%, with operating and profit margins of 9.64% and 0.7%.

    Gross Margin

    n/a
    		 39.07%

    Operating Margin

    n/a
    		 9.64%

    Pretax Margin

    n/a
    		 2.16%

    Profit Margin

    n/a
    		 0.7%

    EBITDA Margin

    n/a
    		 11.93%

    EBIT Margin

    n/a
    		 9.64%

    FCF Margin

    n/a
    		 4.07%

    Dividends & Yields

    BIOX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.46%

    FCF Yield

    n/a
    		 2.71%
    Dividend Details

    Analyst Forecast

    The average price target for BIOX is $7, which is 42% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 42%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $0.26

    Lynch Upside

    n/a
    		 -94.73%

    Graham Number

    n/a
    		 2.41

    Graham Upside

    n/a
    		 -51.12%

    Scores

    Altman Z-Score

    n/a
    		 1.11

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist